These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21127498)

  • 1. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Michallet AS; Rossignol J; Cazin B; Ysebaert L
    Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
    Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
    Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune cytopenias in chronic lymphocytic leukemia.
    D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
    Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia.
    Piatek CI; Bocian H; Algaze S; Weitz IC; O'Connell C; Liebman HA
    Acta Haematol; 2020; 143(3):244-249. PubMed ID: 31665725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
    Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
    Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.
    Nikitin E; Kislova M; Morozov D; Belyakova V; Suvorova A; Sveshnikova J; Vyscub G; Matveeva I; Shirokova M; Shipaeva A; Klitochenko T; Makarovskaya P; Dmitrieva E; Biderman B; Sudarikov A; Obukhova T; Samoilova O; Kaplanov K; Konstantinova T; Mayorova O; Poddubnaya I; Ptushkin V
    Leukemia; 2023 Jul; 37(7):1464-1473. PubMed ID: 37202442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disseminated zygomycosis in a patient with chronic lymphocytic leukemia].
    Sanz-Bueno J; Castellanos-González M; Rodríguez-Peralto JL; Rivera R
    Med Clin (Barc); 2013 Jun; 140(11):e21. PubMed ID: 23537740
    [No Abstract]   [Full Text] [Related]  

  • 11. Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.
    Osterborg A; Karlsson C; Lundin J
    Curr Hematol Malig Rep; 2009 Jan; 4(1):47-53. PubMed ID: 20425438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.
    Zent CS; Shanafelt T
    Leuk Lymphoma; 2009 Jun; 50(6):863-4. PubMed ID: 19455465
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
    Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
    Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
    Tsang M; Parikh SA
    Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia.
    Aleem A
    Ann Saudi Med; 2008; 28(5):382-5. PubMed ID: 18779631
    [No Abstract]   [Full Text] [Related]  

  • 19. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases.
    Zaja F; Vianelli N; Sperotto A; Patriarca F; Tani M; Marin L; Tiribelli M; Candoni A; Baccarani M; Fanin R
    Leuk Lymphoma; 2003 Nov; 44(11):1951-5. PubMed ID: 14738149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.